Souza, G. R., Pettaway, C. A., Campbell, M. T., Neubauer, R., Johns, A., Mizelle, S. R., Kim, Y., Chadha, J., Zhang, J., Jameel, G., Oschmann, E., Dhillon, J., Moscu, A., Janeway, R., Harris, D. W., Lu, X., Spiess, P. E., Chahoud, J. (2025). A phase II trial of dostarlimab and niraparib combination therapy in patients with stage III-IV recurrent or refractory penile cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps14